By contrast, sex (OR = 1.28, 95% CI: 0.79–2.07, comparing males to females), the use of imatinib (0.78, 0.48–1.26), remdesivir (0.71, 0.27–1.88), and tocilizumab (0.99, 0.50–1.96), previous history of vaccination (0.84, 0.47–1.51), BMI (0.99, 0.95–1.04, per kg/m2), history of diabetes mellitus (1.51, 0.89–2.57), history of ischemic heart disease (1.77, 0.89–3.49), platelet counts (1.00, 1.00–1.00, per 1000 increase), CRP (1.04, 0.98–1.10, per 10-unit increase), and troponin (1.03, 0.98–1.07, per 10-unit increase) were not associated with a change in the odds of death at ICU. This evidence concerns the gene CRP and coronary artery disorder.